View |
|
DRP-15467
|
Metformin Hydrochloride
|
Glycemed 750
|
750 mg
|
Extended-Release Tablet
|
Blood glucose lowering drug (Biguanide)
|
Ind-Swift Limited
|
India
|
Initial
|
11 July 2024
|
11 July 2029
|
View |
|
DRP-15452
|
Colchicine
|
Colcifar
|
500 mcg
|
Tablet
|
Antigout Preparation
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
11 July 2024
|
11 July 2029
|
View |
|
DRP-15449
|
Desloratadine
|
Aizene
|
2.5 mg/5 mL
|
Syrup (Mixed Fruit Flavor)
|
Antihistamine
|
Gracure Pharmaceuticals Ltd.
|
India
|
Initial (Reconstruction)
|
10 September 2024
|
12 July 2029
|
View |
|
DRP-15460
|
Cefazolin (as sodium)
|
Zolinova IV
|
1g
|
Dry Powder For Injection
|
Antibacterial (First Generation
|
Finebiotics Pharma Ltd.
|
India
|
Initial
|
11 July 2024
|
11 July 2029
|
View |
|
DRP-15461
|
Cefoxitin (as sodium)
|
Sefozin
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Second-Generation Cephalosporin).
|
Yangtze River Pharmaceutical (Group) Co., Ltd.
|
China
|
Initial
|
11 July 2024
|
11 July 2029
|
View |
|
DRP-15473
|
Gliclazide
|
Proglitab MR 30
|
30 mg
|
Modified-Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Inventia Healthcare Limited
|
India
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15474
|
Vildagliptin + Metformin Hydrochloride
|
Sunvilda-M 50/500
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15475
|
Vildagliptin + Metformin Hydrochloride
|
Sunvilda-M 50/850
|
50 mg/ 850 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15476
|
Vildagliptin + Metformin Hydrochloride
|
Sunvilda-M 50/1000
|
50 mg/1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15477
|
Cefazolin (as sodium)
|
Zolin-IV
|
1 g
|
Powder for Solution for Injection (IM/IV)
|
First-Generation Cephalosporin
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15478
|
Vildagliptin Metformin Hydrochloride
|
Vildariv-M
|
50 mg/ 500 mg
|
Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
East African (India) Overseas
|
India
|
Initial
|
12 July 2024
|
12 July 2029
|
View |
|
DRP-15471
|
Tobramycin
|
Accetob
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
Initial (Re-Application)
|
16 July 2024
|
16 July 2029
|
View |
|
DRP-15484
|
Amiodarone Hydrochloride
|
Saphridarone
|
200 mg
|
Tablet
|
Antiarrythmic Agent
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (Re-Application)
|
16 July 2024
|
16 July 2029
|
View |
|
DRP-15479
|
Pregabalin
|
Maxgalin 300
|
300 mg
|
Capsule
|
Antiepileptic
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
15 July 2024
|
15 July 2029
|
View |
|
DRP-15481
|
Pregabalin
|
Maxgalin 75
|
75 mg
|
Capsule
|
Antiepileptic
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
15 July 2024
|
15 July 2029
|
View |
|
DRP-15482
|
Pregabalin
|
Maxgalin 50
|
50 mg
|
Capsule
|
Antiepileptic
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial
|
15 July 2024
|
15 July 2029
|
View |
|
DRP-15472
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Panfred D
|
40 mg/30 mg
|
Modified Release Capsule
|
Proton Pump Inhibitor/Gastrokinetic (Propulsive)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
16 July 2024
|
16 July 2029
|
View |
|
DR-XY49135
|
Tenofovir Disoproxil Fumarate
|
Tenohope
|
300 mg
|
Film-Coated Tablet
|
Antiviral (Nucleoside/ Nucleotide Reverse
se Transcriptase Inhibitor)
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
16 July 2024
|
16 July 2029
|
View |
|
DRP-15485
|
Ticagrelor
|
Ticagresaph
|
90 mg
|
Film-Coated Tablet
|
Platelet Aggregation Inhibitor Excl. Heparin
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
16 July 2024
|
16 July 2029
|
View |
|
DRP-15483
|
Dapagliflozin (as propanediol monohydrate)
|
Dapastal-10
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug[Sodium-glucose
transporter 2 (SGLT2) Inhibitor]
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
16 July 2024
|
16 July 2029
|